Title : Doxorubicin synergism and resistance reversal in human neuroblastoma BE(2)C cell lines: An in vitro study with dextran-catechin nanohybrids.

Pub. Date : 2018 Jan

PMID : 29129733






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Viability assays on parental BE(2)C and resistant BE(2)C/ADR cell lines proved that the high anticancer activity of dextran-catechin conjugate (IC50 19.9 +- 0.6 and 18.4 +- 0.7 microg mL-1) was retained upon formation of the nanohybrids (IC50 24.8 +- 0.7 and 22.9 +- 1 microg mL-1). Catechin L1 cell adhesion molecule Mus musculus
2 Viability assays on parental BE(2)C and resistant BE(2)C/ADR cell lines proved that the high anticancer activity of dextran-catechin conjugate (IC50 19.9 +- 0.6 and 18.4 +- 0.7 microg mL-1) was retained upon formation of the nanohybrids (IC50 24.8 +- 0.7 and 22.9 +- 1 microg mL-1). Catechin L1 cell adhesion molecule Mus musculus